Video

Findings help investigators understand how FDA-approved AGN-19058 behaves

Author(s):

Kassi Filkins
Conferences|ASCRS

George Waring, MD, discusses the findings of a retrospective study on Allergan’s AGN-190584 for the treatment of presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
August 8th 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 8th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Q&A: The potential impact of vitamin D on retinal surgery
August 8th 2025

Q&A: The potential impact of vitamin D on retinal surgery

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 8th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Updates on faricimab for DME from ASRS 2025
August 8th 2025

Q&A: Updates on faricimab for DME from ASRS 2025

Q&A: A VERONA trial update with Yasha S. Modi, MD
August 8th 2025

Q&A: A VERONA trial update with Yasha S. Modi, MD

© 2025 MJH Life Sciences

All rights reserved.